Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SLCO2B1 |
| Upstream (Parents) |
|---|
| (<<) PPAP2B → SLCO2B1 |
| (<<) GABARAPL1 → SLCO2B1 |
| (<<) TMEM45A → SLCO2B1 |
| Downstream (Children) |
|---|
| SLCO2B1 → EPAS1 (>>) |
| SLCO2B1 → GABARAPL1 (>>) |
| SLCO2B1 → TK2 (>>) |
| SLCO2B1 → GCNT2 (>>) |
| SLCO2B1 → KCNG1 (>>) |
| SLCO2B1 → GPR19 (>>) |
| SLCO2B1 → ARSD (>>) |
| SLCO2B1 → ADAMTS20 (>>) |
| SLCO2B1 → E2F2 (>>) |
| SLCO2B1 → DAPK1 (>>) |
| SLCO2B1 → PI4K2A (>>) |
| SLCO2B1 → MCOLN1 (>>) |
| SLCO2B1 → SEC23A (>>) |
| SLCO2B1 → WDR91 (>>) |
| SLCO2B1 → MCC (>>) |
